One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic ...
DESTIN, Fla. — An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according to a speaker at the Congress of Clinical Rheumatology East ...
Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells rather than autoantibodies, according to data presented at ACR Convergence ...
The combination of glofitamab (Columvi) plus polatzumab vedotin (Polivy) demonstrated high efficacy and durable responses in patients with relapsed/refractory large B-cell lymphoma (LBCL), according ...
Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...
Presented new preclinical data on INB-619, a novel gamma-delta (γδ) T cell engager (TCE), demonstrating equivalent potency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback